HVTN 702 - A phase 2b/3 efficacy trial of ALVAC-HIV and gp120 in preventi to support an efficacy trial of a candidate HIV vaccine in the Republic of South Africa to determine if this vaccine can improve upon the modest efficacy results obtained with a similar vaccine in the “RV144” trial conducted in Thailand.